Clinical Trials Logo

Headache, Migraine clinical trials

View clinical trials related to Headache, Migraine.

Filter by:

NCT ID: NCT04577443 Completed - Headache, Migraine Clinical Trials

The Effect of Adenosine on Cranial Hemodynamic, Headache and Migraine Induction Properties.

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

Adenosine is a nucleoside that plays a role in both vascular and nociceptive systems, and it has been proposed that adenosine may cause headache in particularly sensitive subjects. Thus, considerable evidence implied that adenosine plays a role in migraine pathophysiology, it is still unknown if intravenous adenosine infusion provokes migraine attacks in healthy subject or in migraine patients. Furthermore, adenosine's effects on the cerebral hemodynamic remains unknown. This study aims to clarify a possible coherence between adenosine and headache/migraine. In general, the study will contribute to a greater understanding of migraine pathogenesis and possibly lead to development of specific migraine treatment.

NCT ID: NCT04372264 Active, not recruiting - Headache, Migraine Clinical Trials

Intravenous Paracetamol, Dexketoprofen and Ibuprofen in the Treatment of Acute Migraine Attack Headache

Start date: October 15, 2018
Phase: Phase 4
Study type: Interventional

- Currently, paracetamol and nonsteroidal antiinflammatory drugs are widely used by emergency physicians in Turkey for the treatment of patients with Acute Migraine Attack Headache - The objective of the study is compare the efficacy of intravenous dexketoprofen,ibuprofen with paracetamol in the treatment of acute Migraine Attack Headache

NCT ID: NCT04232605 Recruiting - Headache, Migraine Clinical Trials

Investigation of Vasodilation and Intensity of Headache Triggered by Glucagon Like Peptide-1 in Humans

Start date: January 9, 2020
Phase: N/A
Study type: Interventional

Studying glucagon-like peptide-1 (GLP-1) induced vasodilatory effects on extra - and intracerebral arteries and headache in healthy volunteers and migraine patients without aura.

NCT ID: NCT04111484 Completed - Headache, Migraine Clinical Trials

Adrenomedullin Effect on Migraine Without Patients

Start date: September 28, 2019
Phase: N/A
Study type: Interventional

AM is a naturally occurring peptide in the body and consists of 52 amino acids. AM belongs to the calcitonin gene-related peptide (CGRP) superfamily and has several structural, physiological and pharmacological similarities to CGRP, intermdine and amylin. In a randomized double-blind, placebo controlled cross-over design 20 migraine patients without aura recruited to receive infusion of adrenomedullin or placebo (saline).

NCT ID: NCT04091789 Recruiting - Fatigue Clinical Trials

Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea

Start date: September 2019
Phase: Phase 2
Study type: Interventional

Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea

NCT ID: NCT03967483 Not yet recruiting - Headache, Migraine Clinical Trials

Study on Indomethacin-responsive Headaches

Start date: June 1, 2019
Phase:
Study type: Observational

Description of modalities concerning the patient care of headaches sensible to indometacine.

NCT ID: NCT03887325 Completed - Headache, Migraine Clinical Trials

The Effects of Maxipost (BMS 204352) on Cerebral Hemodynamic and Headache in Healthy Volunteers and Migraine Patients

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

It is not previously investigated whether, there is a correlation between potassium channels and migraine, so it is unclear whether, this signaling pathway through potassium channels has an impact on migraine pathophysiology. Maxipost (BMS 204352) is a vasoactive molecule that causes vasodilation via the big calcium dependent potassium (BKCa) channel signaling pathway. Maxipost decreases the blood pressure and maxipost infusion causes headache in healthy volunteers. A possible coherence between maxipost and headache/migraine in healthy volunteers and migraine patients is yet to be investigated. The present study aims to clarify a possible coherence between maxipost and headache/migraine and it will help to shed light on the importance of potassium channels in migraine. In general, the study will contribute to a greater understanding of migraine pathogenesis and possibly lead to development of specific migraine treatment.

NCT ID: NCT03867864 Not yet recruiting - Quality of Life Clinical Trials

Effects of Aromatherapy on the Headache and Service Quality Among Nurses Working in Critical Care Nurses Units.

Start date: March 15, 2019
Phase: N/A
Study type: Interventional

Background: Our pilot study showed that the prevalence of headaches is 43.5% among nurses working in critical care units in a medical center in Taiwan. In the pilot study, 70% nurses with headache are willing to participate in this intervention study with essential oil. The effect of aromatherapy (essential oils through smelling) is convenient for nurses but still lacks strong evidences regarding relieving headaches. Purpose: Thus, in this intervention study, we will examine whether the necklace with essential oil can (1) improve the pain intensity and frequency of headache; (2) reduce the score of headache disability inventory (HDI) and (3) improve the nurses' quality of life and care quality. Method: Cluster randomized control trial from 16 critical care units at a medical center in Taiwan. The International Classification of Headache Disorders (ICHD, 3rd edition) was used to identify the headache type as "migraine" or "tension-type headache." We will recruit the nurses from 16 critical care units who has migraine or tension-type headache and cluster random assign (according to the ward unit) to group A and B. The intervention of necklace with essential oil will use to compare with the other group. According to power analysis and possible attrition rate, 103 nurses will be recruited. All participants will be asked to complete self-administrated questionnaires, including headache information questions, headache disability inventory (HDI), Migraine Specific Quality of Life Questionnaire version 2.1 (MSQv2.1), Copenhagen burnout inventory (CBI), Service Quality Scale (SERVQUAL), Intention to leave inventory (ITL), Depression, Anxiety and Stress Scale (DASS-21), Tasks Undone-13 (TU-13). The quantitative data will analyze by percentage, mean, standard deviation, chi-square test, and generalized estimating equation (GEE). Expected outcomes and future implications: The aromatherapy (necklace with essential oil) can reduce the pain intensity, frequency, disability of headaches, as well as enhance nurses' quality of life and care quality.

NCT ID: NCT03626805 Completed - Migraine Disorders Clinical Trials

Muscle Tenderness and Hardness in Migraine Patients

Start date: August 13, 2017
Phase:
Study type: Observational

The aim of the study is to examine symptomatology, quantitative sensory test (QST) parameters, muscle tenderness and muscle hardness in migraine patients interictally and compare with healthy controls

NCT ID: NCT03577548 Recruiting - Headache, Migraine Clinical Trials

Influence of Main Psychological and Social Factors on Primary Headaches

CEPHAPSY
Start date: May 2, 2016
Phase:
Study type: Observational

This study aims to describe the psychological and social characteristics of patients suffering from primary headache and monitored in Neurology department of Besançon University Hospital